Chairs: A Diez-Perez, R Eastell

IOF Members: B Abrahamsen, D Agnusdei, D Bauer, ML Brandi, C Copper, E Dennison, P Hadji, M Hiligsmann, R Josse, JA Kanis, L Masi, D Prieto Alhambra, JY Reginster, R Rizzoli, S Silverman

ECTS Members: E Eriksen, N Guanabens, B Obermayer-Pietsch

Co-opted: D Black, D Gold, R Horne, V Rabenda

To define and assess the scope of the adherence problem and outline the consequences of, and factors contributing to, poor adherence.

To review the cause of poor adherence, as well as analysing and recommending adherence-promoting practices.

1. Diez-Perez, A., et al., International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates. Osteoporos Int, 2017. 28(3): p. 767-774.

• Fact Sheet: Using bone turnover markers to detect low adherence to osteoporosis treatment
• Slide Kit: Recommendations for the screening of adherence to oral bisphosphonates
• Interview with Richard Eastell